🇺🇸 FDA
Patent

US 12116597

Autophagy as a therapeutic target for intracranial aneurysm

granted A61KA61K31/351A61K31/37

Quick answer

US patent 12116597 (Autophagy as a therapeutic target for intracranial aneurysm) held by The Board of Regents of the University of Texas System expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/351, A61K31/37, A61K31/404, A61K31/4706